Brian C. Stephenson, See Remarks at BridgeBio Pharma, Inc. (BBIO), sold 13,797 shares at $27.22 ($376K) on 2020-08-03, disclosed to the SEC on 2020-08-05.
Open-market sale of $376k BBIO by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.22 | 4,461 | $121K | 32.3% |
| 2 | $27.22 | 4,461 | $121K | 32.3% |
| 3 | $28.30 | 200 | $6K | 1.5% |
| 4 | $27.20 | 2,136 | $58K | 15.5% |
| 5 | $27.20 | 2,136 | $58K | 15.5% |
| 6 | $27.54 | 403 |
| $11K |
| 3.0% |
| Total | $27.24 avg | 13,797 | $376K | 100% |
| Filing → |
| FTH | BUY | 2026-06-24 | $406K | — | Filing → |
| BBIO | SELL | 2025-02-27 | $282K | — | Filing → |
| BBIO | SELL | 2025-02-19 | $300K | — | Filing → |